Federal Circuit Clarifies Requirement for Reference to Qualify as 'By Another' Under Pre-AIA Sections 102(a) and (e)

November 3, 2025

Reading Time : 2 min

The Federal Circuit recently clarified the requirement for work disclosed in a reference to qualify as “by another” under pre-AIA Sections 102(a) and (e), holding that there must be complete inventive identity between the information disclosed in the asserted reference and the inventors named on the relevant patent. 

This appeal stemmed from two inter partes review proceedings (IPR) in which Hopewell Pharma Ventures challenged Merck Serono’s (Serono) patents, arguing that the prior art references disclosed the claimed dosing regimens. Serono argued that one of the asserted references did not qualify as prior art under pre-AIA Sections 102(a) and (e) because its relevant disclosure, a 6-line dosing regimen, was not “by another” as required by the statute. The PTAB rejected Serono’s defense and found all challenged claims unpatentable.

On appeal, the Federal Circuit considered the question of “whether and to what extent a disclosure invented by fewer than all named inventors of a patent may be deemed a disclosure ‘by another’ and thus included in the prior art.” Serono argued that so long as the relevant disclosure in the reference reflected the work of at least a subset of inventors on the challenged patent, it should not qualify as work “by another.” Rather, it reflected the work of the inventors of the challenged patent. Hopewell, on the other hand, argued that a prior disclosure may only be excluded from the prior art when there is complete identity between the inventors of the disclosure and the inventors named on the challenged patent.

In affirming the PTAB, the Federal Circuit largely adopted Hopewell’s argument. According to the court, for a reference to not be “by another,” and thus not qualify as prior art, the disclosure in the reference must reflect the work of the entire inventive entity of the challenged patent claim. When the challenged claim is the work of joint inventors, the disclosure in the reference must reflect the work of the entire inventive entity of the challenged claim in order to avoid being considered a work “by another.” Overlap between those who contributed to the invention in the disclosure and the inventors on the challenged claim does not exclude a reference as prior art.

Based on the facts of this case the court held that Serono failed to show one of the named inventors on the challenged patent made a significant contribution to the information disclosed in the asserted reference. Thus, that inventor could not be considered a joint inventor of the disclosure, and as a result, the disclosure must be deemed to be part of the prior art as having been made “by another.”

Practice Tip: When preparing or defending patents, especially in collaborative research environments, it is important to carefully document the inventive contributions of each named inventor to be able to show that the inventors of a patent claim are identical to the inventors that disclosed the invention in related publications. This can be critical in later proceedings where the status of prior art may hinge on the degree of overlap between the named inventors and the authors or inventors of a related publication.

Share This Insight

Previous Entries

IP Newsflash

November 17,2025

The district of Delaware recently denied a defendant’s partial motion to dismiss pre-suit willful infringement from the litigation, finding instead that the allegations taken as a whole were sufficient to support pre-suit willfulness at the pleading stage. Specifically, the court found that the allegations as to the defendant’s involvement in a related foreign opposition proceeding and participation in the relevant industry were accompanied by detailed factual support that sufficiently pleaded willful infringement for the pre-suit period.

...

Read More

IP Newsflash

November 14, 2025

The Ninth Circuit recently reversed a district court’s decision to strike a plaintiff’s trade secret claims under the Defend Trade Secrets Act (DTSA) at the discovery stage. In doing so, the Ninth Circuit made clear that under the DTSA, whether a party defined their trade secret with sufficient particularity is a question of fact that generally does not lend itself to resolution in the absence of at least some discovery. This ruling contrasts with the California Uniform Trade Secrets Act (CUTSA), which requires a party to define their trade secrets with reasonable particularity before commencing discovery.

...

Read More

IP Newsflash

November 11, 2025

The Federal Circuit recently vacated a summary judgment ruling of invalidity, holding that the district court erred in applying preclusive effect to the Patent Trial and Appeal Board’s unpatentability findings regarding other claims in the same patent. In doing so, the Federal Circuit reiterated that issue preclusion does not apply where the prior factual determinations were made under a lower standard of proof.

...

Read More

IP Newsflash

November 3, 2025

The Federal Circuit recently clarified the requirement for work disclosed in a reference to qualify as “by another” under pre-AIA Sections 102(a) and (e), holding that there must be complete inventive identity between the information disclosed in the asserted reference and the inventors named on the relevant patent. 

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.